Leaflet LARINATE 60mg powder for solution for injection

Product code:
W61957001
Quantity:
1
Indicated for:
malaria
Route of administration:
injectable
Substance:
artesunate (antimalarial)
ATC
P01BE03 — Antiparasitic products, insecticides and repellents | Antimalarials | Artemisinin and derivatives, plain
Artesunate is a medication used in the treatment of severe malaria caused by Plasmodium falciparum. It is a semisynthetic derivative of artemisinin that acts rapidly against the parasite by generating reactive oxygen species that destroy infected cells.

Artesunate is administered intravenously or intramuscularly and is recommended in cases of severe malaria, particularly in patients who cannot tolerate oral therapy. It is often used in combination with other antimalarial drugs to prevent recurrence of the infection.

Common side effects include nausea, dizziness, fever, and injection site reactions. In rare cases, severe allergic reactions or delayed hemolysis may occur, requiring careful monitoring.

Artesunate is an essential medication in the treatment of severe malaria, helping to reduce mortality and improve outcomes for patients affected by this serious disease.

General data about LARINATE 60mg

Substance:
artesunate
Date of latest medicines list:
01-06-2016
Product code:
W61957001
Concentration:
60mg
Pharmaceutical form:
powder for solution for injection
Quantity:
1
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Concentrations available for artesunate

  • 110mg
  • 60mg